Clinical Trial Update: A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating safety and efficacy of oral PTH (1-34) for hypoparathyroidism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• Oral PTH (1-34) (parathyroid hormone (1-34))

Snippet

Sponsor: Entera Bio Ltd. | Conditions: Hypoparathyroidism | Phase 2 | Status: COMPLETED